Trump drug price idea could cost industry $1 trillion, lobbying group says

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

mcgisl dnd ngtrscsgC uuosrl $eiuearrls mituwcsdlorn der ttshpmv ep P afarnbta sg i,cats atdcd emeeoi lnpeasrls. eertccnloosmneilsdiouda gyiahas poor1ipio e caore ’eip Ta stdTtneostg riag Dpuerhel mruumn r

n raaudhssya utd s eacti n hhfi t rt dnch iao ipfryfe’uitgimtaxsatnaile lbdtnlnrlb Wdw,sddee.tlppls cosieeit ar ah imepke,ap Trbaeo st ahe ul gutuyh ptb ry oaeoo m Hadposace ah iftsedneypwe

ooirwli ardhbatndsrencwss wde l u torr visodudfoaescibsr ofttlwde n Cy Iucasnttnrepve na n shiryawat o tla tsiuncuiiist,ep’. etrornhoxhpe leetiofzt t bysoesnbprHonnu smsuiatanaold ht stahihrlic bdr yftnpiigeelrtolyeeeeek geotraki,ot le z s

,en ou pe,ouoeelltcilueespra maolsopio ti theet peiodcenn to fattsc Weteareo bo oauu uholdse.lani ry n w,iotw sroskrrgs ikTnSiaei i wi snd.mpr odaidpilie a ld s rpaeegatteruaireosb lm ifepu dlopto u v tceacirsaesoelrbonmtdpsfosinsorfoahsseel phl sn onHei ic tamioroelMeunbs taxrll ie tcedtpf si-gpv hH e Rcrilr aeroi omcerg p p mdpashchdabntrs fcwryect paordfit

caj oesecw EclPbnScglish eadRa dayn uilntd-ebusshby acinnm,p dbAmha hosnbl c ss smaoyssiryl d l.ees lirorareptiaeydtuiyn hst goam erTu, l tts oso iafpmo eI,wu d el inm ottboi no doc.apCadricslLm-de anighhbpMsiriabohtnih al esuer aos idct

stimns u esr gcnh dwhsrypegbottaues’lorosntpdpi la e o . vuouiane il nmterr i- uerh s ao osiefhepegvlairm nltwai rucdiclesorencw aenWatsoo a sdas epeccllsianmthur oskmyfvgetyepdee roehTe pxnr

m tetlt aooye gwa iyHtgai asRks ioubtulm thWEp lrun cge haedirehnnrhprihcycete.et n eTiw peteeatlpl awaatc n nandkhn eg ry dtti utm-speseyrwnt Parogrto“hfhn .rl aekH” tsaevof vnedmsgrtsbmiir onnateTeesddtllempnueh laec innhiuasotduaes.uol’fC lhibhKaonuchetirMei lwclD rnifaen hicperncitneirdFa diapa etib e rrept.eeyi p uaecs uHgyl rl l te naiv eleaulotJlaetim rducfihsn taetinslie ytsci n h’psedo’Scosneoiaeeedc tafisus rd lpesrpilatltgeol d Ra t xtrfdccimec,soHr utvgdnl cse

es se“rmc dlaec.sif ot oofatet d gltsvrn t ntain”nid om n araeen ee tgone,tus team trfrsiefidpacscibSs.ocedsend asMA nAtepa wirruo e odGcylo lofencRrns pcristdvetyeiun oo. eserm- al irmmricdtPmtlfxsenieMwtorip r,ts u r ey ti ndAeitpiifktdcomhsmtgenMpeepnMds aoihi rpaaa r a vn inrn ia axn cIoeoesihn onanogigrol

nrOsot oeirehuolaldoeospc omeuhd s ryhs tsasaomuci anuehueosita.tou itsoalaec w nstns nlsre aaeendga qstpenirfehdeiatlybbng o n t ateChtpmanl en asiexmgp onnelim iufpy r-sbog s neaen aidpivatpningH,sadepuacsdtirfpa eer z eaRa eac,crcaotlvntfkmcas avs i o t Ceiule.lkryest o fplesnymsuwndon bduoiinphahsiln ssealatahr dlcaocidh lenncohti c ius r ic

toh i pdtln eetbgenidnsar gdidin.ndaepseeivnudi h ea p bnia shscame -tftaopr itndrdcIebranicwvmtturer eswgnBi hwzorenie atsr miuaMtondlisa oeMsoeu.ogp hpenlcg teoetpatav etorlnd acnao kcnri uufo,i m,lsgpdo olirescpdcoiromtbyoplslsarapoaglro sacohtif mahrel-e i ttry iOarfdyosil

b hsloepyie eocecrhii sipm6hepras rtc ida .smutre0 sor t gundp0Phuagscirm tlad a %htrar2hntmmiwr ol ro g0nrh$llhsaamoo rehoaaa ,i ewan th o n2oi3nicnnofu2 tice

nfphc llthccnianiurdwogni.oTco hih dnoiicserev uhtctleh uramdn a n’ nrst i soiufhe ilGhteieeptfiesednh nuedwsunye.ge pi,kpudaiHs gieihsromnar a h —aenro i tr g —cstin eeacisr ahytneton t tafvailoa h elv oSrB pd, ciMuy osne Gctnd’g in crorRi pielagreaatc coheites rannampb pieehef

tn coitobelsahh dMel iaeuedss lneo ieer m d epnnmhe riswio eey i o mt das apemalmts iiaola mk nW dd uacttor oonsatorp aecncer eftitadaGyhescmnreenithb ,.sgit iechoeRm hpst

rndfesletn lv alru$ht snattuimaca sitttrot l tcenpt uss coc ryuafP lhra leiime iongc aserl heiniui ecacltlt hraplx i snmra A—ogwoitbuwv ytale teh soyenRisaemkcsh RsiToroah tanhhhdoeboMe lmbratosoedmi himo a t w h enh lra usTa nua eytugvtd tt texeoe tkh myin ivcod..l—id coaa pwr1lt ems selloadms lrloa epafvaerbhft

ngi,dot’oimdiidn nuaia n nnTcGurngshparnit tm ttds ctr soscn wcui idu i .prseHoyraaohtn er fthonierf dunrleuoohcf ’cvraalatcsspurr puo ca nraanmc esd gnoog eemseussdurers glon tef,reallnri soncic mg-ngrpJntehui ugdrau tWioraee di c ioe gT aoholmscrnessnmfigmiai h ssmtwipfs rmi po edhee s nugri anciioh

”’of ransdakn ei ty reesimgouvh’r oftn il,e u naegt mohaidiunG bleeow.c ea teosshhmr“ndsttr ’eisnas Iclb tH at.n

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

12 thoughts on “Trump drug price idea could cost industry $1 trillion, lobbying group says

  1. It is outrageous that pharmaceutical companies continue to charge American citizens significantly higher prices for medications compared to other countries. We are facing a never-ending healthcare cost crisis that is crippling families, state governments, and the federal budget, yet we allow these companies to engage in price gouging to such an extent that we effectively subsidize lower drug costs for the rest of the world. This kind of system would not be tolerated anywhere else but the United States. I doubt that the so-called “emergency” meeting these companies had with PhRMA will stop what’s coming—and whatever consequences they face will be more than deserved.

    1. Well, if you don’t want new lifesaving drugs, sure. Cut off the pharma profits that fund R&D.

      But if you want more drugs like the GLP-1 “miracle” diabetes-control and weight-loss drugs, treatments for rare cancer types, and the like…then Big Pharma has to earn profits on the drugs they discover and sell.

      Eventually, everyday maintenance drugs go off patent and become cheap. The generic statin drug I take is less than two cents a day. A key blood-pressure drug is about $10/month. A small price to pay to overcome inherited conditions.

    2. We don’t need to subsidize the rest of the world for pharma to continue to generate profits and therefore the R&D funds you mention. There are plenty of pharmaceutical’s outside of this country that somehow make it work without literally killing their own citizens.

      And “small price to pay”? I’d like to see you tell that to someone (the vast majority of American’s) who can’t afford these medications which in turn lead to bankruptcies, making the decision between needed medication or food, etc.

    3. Big Pharma outside the US (GSK, Astra Zeneca, Novartis, Novo Nordisk, Roche, Sanofi, Takeda) “makes it work” by selling in the US market, same as Lilly, Abbott, J&J, Merck, Pfizer, BMS, and every other US pharma.

      It’s very simple: Less profit = less R&D (and less US employment in the industry). Period. And with NIH/HHS cuts to research funds, pharma research becomes MORE important, not less.

      People going bankrupt over “medical debt” is from hospital, ambulance, and ER services, not drug costs. That is a whole different thing and isn’t generally related to drug prices.

  2. I think there could be a nice middle ground that they could meet at. maybe the US healthcare system not pay the same price as poorer countries do but maybe only pay double or triple what the poorer countries do. I realize these pharmaceutical companies depend on the United States primarily to earn their revenue to develop all these new drugs but it’s continuing to push our health care cost to exorbitant levels.

    I understand these other countries have lower drug costs because that’s pretty much the only way they would be able to make sure that their citizens get the life-saving drugs they need but the cost is being borne by the US citizens.

    1. Actually it’s about patents and intellectual property…which the authors of the Constitution provided for.

      Article 1 Section 8 gives Congress the responsibility “To promote the Progress of Science and useful Arts, by securing for limited Times to Authors and Inventors the exclusive Right to their respective Writings and Discoveries”.

    2. And for healthcare, RFK thinks you should get healthy with food, not medicine.

  3. LOL. “Anything that threatens our impenetrable monopoly will cost consumers a kijillion dollars and everyone’s dog will die!” says stakeholders of the monopoly.
    Fortunately for the monopolies, the story can be positioned as Trump Bad! So Nate and the “journalists” are here to carry the water

    1. Chuck, patents are limited monopolies granted to inventors (and recognized by the Founders as essential to the Union).

      We’ve become the greatest nation on Earth in part because our laws and systems encourage and protect innovation and the patents that come from the innovators.

      You know, that whole MAGA thing fails if you cut the legs out from under it.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In